581
Views
1
CrossRef citations to date
0
Altmetric
Research Article

A predictive nomogram developed and validated for gastric cancer patients with triple-negative tumor markers

, , , , , & ORCID Icon show all
Pages 919-934 | Received 22 Jul 2023, Accepted 20 Sep 2023, Published online: 03 Nov 2023

References

  • Sung H , FerlayJ , SiegelRLet al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.71(3), 209–249 (2021).
  • Sekiguchi M , OdaI , MatsudaTet al. Epidemiological trends and future perspectives of gastric cancer in eastern Asia. Digestion103(1), 22–28 (2022).
  • Wang JL , YangYB , GengYXet al. Trend analysis of the morbidity, prevalence and mortality of stomach cancer in China from 1990 to 2017. Chin. J. Prevent. Control Chronic Dis.28(5), 321–325 (2020).
  • Yang L , KartsonakiC , YaoPet al. The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: a case–cohort study. Lancet Public Health6(12), e888–e896 (2021).
  • Yu Y , ZhangZ , DongXet al. Pangenomic analysis of Chinese gastric cancer. Nat. Commun.13(1), 5412 (2022).
  • Jin G , LvJ , YangMet al. Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study. Lancet Oncol.21(10), 1378–1386 (2020).
  • López MJ , CarbajalJ , AlfaroALet al. Characteristics of gastric cancer around the world. Crit. Rev. Oncol. Hematol.181, 103841 (2023).
  • Olefson S , MossSF. Obesity and related risk factors in gastric cardia adenocarcinoma. Gastric Cancer18(1), 23–32 (2015).
  • Japanese Gastric Cancer Association . Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer24(1), 1–21 (2021).
  • Wang FH , ZhangXT , LiYFet al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun. (Lond.)41(8), 747–795 (2021).
  • Lordick F , CarneiroF , CascinuSet al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann. Oncol.33(10), 1005–1020 (2022).
  • Lin Y , DochertySL , PorterLSet al. Common and co-occurring symptoms experienced by patients with gastric cancer. Oncol. Nurs. Forum47(2), 187–202 (2020).
  • Nie Y , WuK , YuJet al. A global burden of gastric cancer: the major impact of China. Expert Rev. Gastroenterol. Hepatol.11(7), 651–661 (2017).
  • Schmidt N , PeitzU , LippertHet al. Missing gastric cancer in dyspepsia. Aliment. Pharmacol. Ther.21(7), 813–820 (2005).
  • Kono Y , KanzakiH , IwamuroMet al. Reality of gastric cancer in young patients: the importance and difficulty of the early diagnosis, prevention and treatment. Acta Med. Okayama74(6), 461–466 (2020).
  • Zhu J , HanY , NiWet al. Nomogram-based survival predictions and treatment recommendations for locally advanced esophageal squamous cell carcinoma treated with upfront surgery. Cancers (Basel)14(22), 5567 (2022).
  • Yang J , GongY , LamVKet al. Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer. Cell Death Dis.11(5), 346 (2020).
  • Joshi SS , BadgwellBD. Current treatment and recent progress in gastric cancer. CA Cancer J. Clin.71(3), 264–279 (2021).
  • Zhang Z , WuH , ChongWet al. Liquid biopsy in gastric cancer: predictive and prognostic biomarkers. Cell Death Dis.13(10), 903 (2022).
  • Tang XH , GuoT , GaoXYet al. Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications. Mol. Cancer20(1), 99 (2021).
  • Shimada H , NoieT , OhashiMet al. Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer17(1), 26–33 (2014).
  • Guo J , ChenS , LiSet al. A novel classifier based on three preoperative tumor markers predicting the cancer-specific survival of gastric cancer (CEA, CA19-9 and CA72-4). Oncotarget9(4), 4814–4822 (2017).
  • Liu X , CaiH , WangY. Prognostic significance of tumour markers in Chinese patients with gastric cancer. ANZ J. Surg.84(6), 448–453 (2014).
  • Feng F , TianY , XuGet al. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer. BMC Cancer17(1), 737 (2017).
  • Guo X , LvX , RuYet al. Circulating exosomal gastric cancer-associated long noncoding RNA1 as a biomarker for early detection and monitoring progression of gastric cancer: a multiphase study. JAMA Surg.155(7), 572–579 (2020).
  • Chen C , ChenQ , ZhaoQet al. Value of combined detection of serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the diagnosis of gastric cancer. Ann. Clin. Lab. Sci.47(3), 260–263 (2017).
  • Yu H . Reference intervals for gastrointestinal tumor markers (AFP, CEA, CA199 and CA724) in healthy adults of Han nationality in Chongqing by Roche ECLIA system. Scand. J. Clin. Lab. Invest.79(7), 484–490 (2019).
  • Wong SL , KattanMW , McMastersKMet al. A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system. Ann. Surg. Oncol.12(4), 282–288 (2005).
  • Camp RL , Dolled-FilhartM , RimmDL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin. Cancer Res.10(21), 7252–7259 (2004).
  • Iasonos A , SchragD , RajGVet al. How to build and interpret a nomogram for cancer prognosis. J. Clin. Oncol.26(8), 1364–1370 (2008).
  • Clark TG , BradburnMJ , LoveSBet al. Survival analysis part I: basic concepts and first analyses. Br. J. Cancer89(2), 232–238 (2003).
  • Liu Y , WuJ , HuangWet al. Development and validation of a hypoxia-immune-based microenvironment gene signature for risk stratification in gastric cancer. J. Transl. Med.18(1), 201 (2020).
  • Baqar AR , WilkinsS , WangWet al. Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer. BMC Cancer20(1), 762 (2020).
  • Zhou YC , ZhaoHJ , ShenLZ. Preoperative serum CEA and CA19-9 in gastric cancer – a single tertiary hospital study of 1,075 cases. Asian Pac. J. Cancer Prev.16(7), 2685–2691 (2015).
  • Gong X , ZhangH. Diagnostic and prognostic values of anti-Helicobacter pylori antibody combined with serum CA724, CA19-9, and CEA for young patients with early gastric cancer. J. Clin. Lab. Anal.34(7), e23268 (2020).
  • Sun Z , ZhangN. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy. World J. Surg. Oncol.12, 397 (2014).
  • Gao C , KongN , ZhangFet al. Risk stratification of lung adenocarcinoma using a nomogram combined with ferroptosis-related LncRNAs and subgroup analysis with immune and N6-methyladenosine modification. BMC Med. Genomics15(1), 15 (2022).
  • Huang S , XieX , SunYet al. Development of a nomogram that predicts the risk for coronary atherosclerotic heart disease. Aging (Albany NY)12(10), 9427–9439 (2020).
  • Slagter AE , VolleberghMA , CaspersIAet al. Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial. Gastric Cancer25(2), 401–410 (2022).
  • Xu Y , ZhangP , ZhangKet al. The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer. Biochim. Biophys. Acta Rev. Cancer1876(2), 188634 (2021).
  • Matsuoka T , YashiroM. Biomarkers of gastric cancer: current topics and future perspective. World J. Gastroenterol.24(26), 2818–2832 (2018).
  • Yu L , JiangR , ChenWet al. Novel prognostic indicator combining inflammatory indicators and tumor markers for gastric cancer. World J. Surg. Oncol.21(1), 50 (2023).
  • Yan J , ShaoY , LuHet al. Hsa_circ_0001020 serves as a potential biomarker for gastric cancer screening and prognosis. Dig. Dis. Sci.67(8), 3753–3762 (2022).
  • Tian W , PangX , LuanF. Diagnosis value of miR-181, miR-652, and CA72-4 for gastric cancer. J. Clin. Lab. Anal.36(6), e24411 (2022).
  • Qiu X , ShenC , ZhaoWet al. Prognostic value of the combination of HB (hemoglobin) and CEA in resectable gastric cancer. J. Cancer13(7), 2246–2257 (2022).
  • Wang J , HassettJM , DaytonMTet al. The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer. J. Gastrointest. Surg.12, 1790–1796 (2008).
  • Vinh-Hung V , VerschraegenC , PromishDIet al. Ratios of involved nodes in early breast cancer. Breast Cancer Res.6, R680–R688 (2004).
  • Luo Z , FuZ , LiTet al. Development and validation of the individualized prognostic nomograms in patients with right- and left-sided colon cancer. Front. Oncol.11, 709835 (2021).
  • Sun Z , XuY , LiDMet al. Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection. Cancer116(11), 2571–2580 (2010).
  • Gu P , DengJ , SunZet al. Superiority of log odds of positive lymph nodes (LODDS) for prognostic prediction after gastric cancer surgery: a multi-institutional analysis of 7620 patients in China. Surg. Today51(1), 101–110 (2021).
  • Liu H , DengJ , ZhangRet al. The RML of lymph node metastasis was superior to the LODDS for evaluating the prognosis of gastric cancer. Int. J. Surg.11(5), 419–424 (2013).
  • Sylman JL , MitrugnoA , AtallahMet al. The predictive value of inflammation-related peripheral blood measurements in cancer staging and prognosis. Front. Oncol.8, 78 (2018).
  • Fankhauser CD , SanderS , RothLet al. Systemic inflammatory markers have independent prognostic value in patients with metastatic testicular germ cell tumours undergoing first-line chemotherapy. Br. J. Cancer118(6), 825–830 (2018).
  • Lin JX , WangZK , HuangYQet al. Dynamic changes in pre- and postoperative levels of inflammatory markers and their effects on the prognosis of patients with gastric cancer. J. Gastrointest. Surg.25(2), 387–396 (2021).
  • Sato S , KunisakiC , TakahashiMet al. High postoperative neutrophil–lymphocyte ratio and low preoperative lymphocyte–monocyte ratio predict poor prognosis in gastric cancer patients receiving gastrectomy with positive lavage cytology: a retrospective cohort study. Langenbecks Arch. Surg.406(7), 2295–2303 (2021).
  • Ma JY , LiuQ. Clinicopathological and prognostic significance of lymphocyte to monocyte ratio in patients with gastric cancer: a meta-analysis. Int. J. Surg.50, 67–71 (2018).
  • Wang H , JinW , WanCet al. Diagnostic value of combined detection of CA72-4, CA19-9, and carcinoembryonic antigen comparing to CA72-4 alone in gastric cancer: a systematic review and meta-analysis. Transl. Cancer Res.11(4), 848–856 (2022).
  • Chen XZ , ZhangWK , YangKet al. Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population. Mol. Biol. Rep.39(9), 9031–9039 (2012).